Zobrazeno 1 - 10
of 92
pro vyhledávání: '"JS Bomalaski"'
Autor:
MJ Evans, L Old, G Ritter, E Rosenfeld, AA Jungbluth, Lars Stelter, SM Larson, JS Bomalaski, P Zanzonico, T Ku
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e22cf078118153c2a437ed1274e78b52
https://doi.org/10.1055/s-0032-1311120
https://doi.org/10.1055/s-0032-1311120
Autor:
Abdelrahman AA; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA. Electronic address: aamar@wustl.edu., Sandow PV; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA., Wang J; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA., Xu Z; Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA., Rojas M; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, 30912 USA; Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA., Bomalaski JS; Polaris Pharmaceuticals, Inc., San Diego, CA 92121, USA., Lemtalsi T; Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA., Caldwell RB; Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA., Caldwell RW; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, 30912 USA; Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA 30912 USA. Electronic address: wcaldwel@augusta.edu.
Publikováno v:
Molecular metabolism [Mol Metab] 2024 Nov; Vol. 89, pp. 102020. Date of Electronic Publication: 2024 Aug 29.
Autor:
Rogers LC; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri., Kremer JC; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri., Brashears CB; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri., Lin Z; Department of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, Missouri., Hu Z; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Bastos ACS; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri., Baker A; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri., Fettig N; Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Zhou D; Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Shoghi KI; Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri., Dehner CA; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Chrisinger JSA; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Bomalaski JS; Polaris Pharmaceuticals, Inc., San Diego, California., Garcia BA; Department of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, Missouri., Oyama T; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri., White EP; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey., Van Tine BA; Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri.; Division of Pediatric Hematology/Oncology, St. Louis Children's Hospital, St. Louis, Missouri.; Siteman Cancer Center, St. Louis, Missouri.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 3189-3202.
Autor:
Chan PY; Department of Medical Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Phillips MM; Department of Medical Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Ellis S; Department of Medical Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Johnston A; Polaris Pharmaceuticals Inc, San Diego, California, USA., Feng X; Polaris Pharmaceuticals Inc, San Diego, California, USA., Arora A; Department of Ocular Oncology, Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK., Hay G; Department of Ocular Oncology, Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK., Cohen VML; Department of Ocular Oncology, Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK., Sagoo MS; Department of Ocular Oncology, Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London, UK.; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, UK., Bomalaski JS; Polaris Pharmaceuticals Inc, San Diego, California, USA., Sheaff MT; Department of Histopathology, Royal London Hospital, Barts Health NHS Trust, London, UK., Szlosarek PW; Department of Medical Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2022 Jul; Vol. 35 (4), pp. 461-470. Date of Electronic Publication: 2022 May 16.
Autor:
Kraehenbuehl L; Ludwig Collaborative and Swim Across America Laboratory, Parker Institute for Cancer Immunotherapy, Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Holland A; Ludwig Collaborative and Swim Across America Laboratory, Parker Institute for Cancer Immunotherapy, Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Armstrong E; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., O'Shea S; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Mangarin L; Ludwig Collaborative and Swim Across America Laboratory, Parker Institute for Cancer Immunotherapy, Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Chekalil S; Ludwig Collaborative and Swim Across America Laboratory, Parker Institute for Cancer Immunotherapy, Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Johnston A; Polaris Pharmaceuticals, Inc., San Diego, CA 92121, USA., Bomalaski JS; Polaris Pharmaceuticals, Inc., San Diego, CA 92121, USA., Erinjeri JP; Department of Radiology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Francis JH; Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Wolchok JD; Ludwig Collaborative and Swim Across America Laboratory, Parker Institute for Cancer Immunotherapy, Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.; Weill Cornell Medical College; New York, NY 10065, USA., Merghoub T; Ludwig Collaborative and Swim Across America Laboratory, Parker Institute for Cancer Immunotherapy, Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.; Weill Cornell Medical College; New York, NY 10065, USA., Shoushtari AN; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.; Weill Cornell Medical College; New York, NY 10065, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2022 May 26; Vol. 14 (11). Date of Electronic Publication: 2022 May 26.
Autor:
Zhang Y; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA., Higgins CB; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA., Van Tine BA; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.; Division of Pediatric Hematology/Oncology, St. Louis Children's Hospital, St. Louis, MO 63108, USA.; Siteman Cancer Center, St. Louis, MO 63108, USA., Bomalaski JS; Polaris Pharmaceuticals, Inc., San Diego, CA 63110, USA., DeBosch BJ; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.; Department of Cell Biology & Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2022 Jan 18; Vol. 3 (1), pp. 100498. Date of Electronic Publication: 2022 Jan 18 (Print Publication: 2022).
Autor:
Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Yang TS; Internal Medicine, Linkou Chang Gung Medical Foundation, Taoyuan City, Taiwan., Chen YY; College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan., Feng YH; Internal Medicine, Chi Mei Medical Center, Tainan City, Taiwan., Yen CJ; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan., Ho CL; Division of Hematology, Department of Medicine, National Defense Medical Center, Tri-Service General Hospital, Taipei City, Taiwan., Huang WT; Department of Medicine, Chi Mei Medical Center-Liouying, Tainan City, Taiwan., El Dika I; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Akce M; Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Tan B; Department of Medicine, Washington University in St Louis, St Louis, Missouri., Cohen SA; Oncology, University of Washington, Seattle, Washington., Meyer T; Oncology, Royal Free Hospital, London, United Kingdom., Sarker D; Department of Medicine, Guys Hospital, London, United Kingdom., Lee DW; Internal Medicine, Seoul National University Hospital, Seoul, Korea., Ryoo BY; Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lim HY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea., Johnston A; Polaris Pharmaceuticals, Inc, San Diego, California., Bomalaski JS; Polaris Pharmaceuticals, Inc, San Diego, California., O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Qin S; Cancer Center, Bayi Hospital of Nanjing Chinese Medicine University, Nanjing, China., Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.
Publikováno v:
Cancer [Cancer] 2021 Dec 15; Vol. 127 (24), pp. 4585-4593. Date of Electronic Publication: 2021 Aug 20.
Autor:
Chang KY; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Chiang NJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Wu SY; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chen SH; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Yeh YM; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Li CF; Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Feng X; Polaris Pharmaceuticals, Inc., San Diego, California, USA., Wu K; Polaris Pharmaceuticals, Inc., San Diego, California, USA., Johnston A; Polaris Pharmaceuticals, Inc., San Diego, California, USA., Bomalaski JS; Polaris Pharmaceuticals, Inc., San Diego, California, USA., Wu BW; Polaris Pharmaceuticals, Inc., San Diego, California, USA., Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Subudhi SK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Blando JM; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Yadav SS; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Szlosarek PW; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, UK., Chen LT; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2021 Jul 12; Vol. 10 (1), pp. 1943253. Date of Electronic Publication: 2021 Jul 12 (Print Publication: 2021).
Autor:
Tsai HJ; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; Department of Oncology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.; Division of Hematology/Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Hsiao HH; Division of Hematology/Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Hsu YT; Division of Hematology, Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan., Liu YC; Division of Hematology/Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Kao HW; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Linkou, Taiwan., Liu TC; Division of Hematology/Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Division of Hematology-Oncology and Cancer Center, Chang Bing Show Chwan Hospital, Changhua, Taiwan., Cho SF; Division of Hematology/Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Feng X; Polaris Pharmaceuticals, Inc, Polaris Group, San Diego, CA, USA., Johnston A; Polaris Pharmaceuticals, Inc, Polaris Group, San Diego, CA, USA., Bomalaski JS; Polaris Pharmaceuticals, Inc, Polaris Group, San Diego, CA, USA., Kuo MC; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Linkou, Taiwan., Chen TY; Division of Hematology, Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
Publikováno v:
Cancer medicine [Cancer Med] 2021 May; Vol. 10 (9), pp. 2946-2955. Date of Electronic Publication: 2021 Mar 30.
Autor:
Hall PE; Department of Medical Oncology, Barts Health NHS Trust, London, United Kingdom., Ready N; Department of Medicine, Duke University Medical Center, Durham, NC., Johnston A; Medical Affairs, Polaris Pharmaceuticals Inc., San Diego, CA., Bomalaski JS; Medical Affairs, Polaris Pharmaceuticals Inc., San Diego, CA., Venhaus RR; Cancer Trials Management, Ludwig Institute for Cancer Research, New York, NY., Sheaff M; Department of Pathology, Barts Health NHS Trust, London, United Kingdom., Krug L; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Szlosarek PW; Department of Medical Oncology, Barts Health NHS Trust, London, United Kingdom; Centre for Molecular Oncology, Queen Mary University of London, London, United Kingdom. Electronic address: p.w.szlosarek@qmul.ac.uk.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2020 Nov; Vol. 21 (6), pp. 527-533. Date of Electronic Publication: 2020 Jul 30.